Annals of Medicine
Annals of Medicine is a journal indexed in SJR in Medicine (miscellaneous) with an H index of 133. It has a price of 2395 €. It has an SJR impact factor of 1,204 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,204.
Annals of Medicine focuses its scope in these topics and keywords: disease, bone, mortality, patients, allergic, cutaneous, coronary, diabetes, casecontrol, coagulopathyare, ...
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
1,204
H-index
133
Docs (year)
446
Docs 3y
1086
Total refs
23221
Cites 3y
4941
Citable 3y
1060
Cites/Doc 2y
4.44
Ref/Doc
52.07
Immediate OA
2395 €
Embargoed OA
NPD
Non OA / Submission
0 €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Blood Pressure Regulation during Exercise
View moreWhat is a pathogen?
View moreDISC1 and DISC2: discovering and dissecting molecular mechanisms underlying psychiatric illness
View moreDifferences in the activation patterns between sustained and self-terminating episodes of human ventricular fibrillation
View moreDental Caries, Sugars and Xylitol
View moreCytokines in Rheumatoid Arthritis
View moreComplement activation in Puumala hantavirus infection correlates with disease severity
View moreCollagens and their Abnormalities in a Wide Spectrum of Diseases
View moreClinical review: Inferior vena cava filters in the age of patient-centered outcomes
View moreClinical response to statins: Mechanism(s) of variable activity and adverse effects
View moreCentral line-associated bloodstream infections caused by Staphylococcus aureus in cancer patients: clinical outcome and management
View moreCardiac Natriuretic Peptides in Heart Failure
View moreCarcinomatosis from gastrointestinal cancer
View moreA fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: Results from two randomized, parallel-group, placebo-controlled trials
View moreBlack dog barks at brown fat
View moreBeyond weight reduction: Improvements in quality of life after an intensive lifestyle intervention in subjects with severe obesity
View moreAssociation of sleep-disordered breathing with diabetes-associated kidney disease
View moreAssessment of response to therapy in hepatocellular carcinoma
View moreAssessing airway inflammation: from guessing to quantitative measurements
View moreArterial elasticity and oxidized LDL among men with metabolic syndrome and different 10-year cardiovascular risk estimated by FINRISK and SCORE models
View moreAn insight into molecular mechanisms of human T helper cell differentiation
View moreAdvancing management of hypertension through pharmacogenomics
View moreABCA1: regulation, trafficking and association with heteromeric proteins
View moreA six-fold gradient in the incidence of type 1 diabetes at the eastern border of Finland
View more